162 related articles for article (PubMed ID: 37557892)
21. RAS/RAF mutations and their associations with epigenetic alterations for distinct pathways in Vietnamese colorectal cancer.
Ta TV; Nguyen QN; Chu HH; Truong VL; Vuong LD
Pathol Res Pract; 2020 Apr; 216(4):152898. PubMed ID: 32089414
[TBL] [Abstract][Full Text] [Related]
22. Prognostic Value of BRAF and KRAS Mutation in Relation to Colorectal Cancer Survival in Iranian Patients: Correlated to Microsatellite Instability.
Nazemalhosseini-Mojarad E; Kishani Farahani R; Mehrizi M; Baghaei K; Yaghoob Taleghani M; Golmohammadi M; Peyravian N; Ashtari S; Pourhoseingholi MA; Asadzadeh Aghdaei H; Zali MR
J Gastrointest Cancer; 2020 Mar; 51(1):53-62. PubMed ID: 30635874
[TBL] [Abstract][Full Text] [Related]
23. Context-dependent interpretation of the prognostic value of BRAF and KRAS mutations in colorectal cancer.
Popovici V; Budinska E; Bosman FT; Tejpar S; Roth AD; Delorenzi M
BMC Cancer; 2013 Sep; 13():439. PubMed ID: 24073892
[TBL] [Abstract][Full Text] [Related]
24. Mutation status and prognostic value of KRAS and NRAS mutations in Moroccan colon cancer patients: A first report.
El Agy F; El Bardai S; El Otmani I; Benbrahim Z; Karim MH; Mazaz K; Benjelloun EB; Ousadden A; El Abkari M; Ibrahimi SA; Chbani L
PLoS One; 2021; 16(3):e0248522. PubMed ID: 33784337
[TBL] [Abstract][Full Text] [Related]
25. Follistatin-Like 3 Correlates With Lymph Node Metastasis and Serves as a Biomarker of Extracellular Matrix Remodeling in Colorectal Cancer.
Yang C; Cao F; Huang S; Zheng Y
Front Immunol; 2021; 12():717505. PubMed ID: 34335633
[TBL] [Abstract][Full Text] [Related]
26. Prognostic impact of KRAS, NRAS, BRAF, and PIK3CA mutations in primary colorectal carcinomas: a population-based study.
Palomba G; Doneddu V; Cossu A; Paliogiannis P; Manca A; Casula M; Colombino M; Lanzillo A; Defraia E; Pazzola A; Sanna G; Putzu C; Ortu S; Scartozzi M; Ionta MT; Baldino G; Sarobba G; Capelli F; Sedda T; Virdis L; Barca M; Gramignano G; Budroni M; Tanda F; Palmieri G
J Transl Med; 2016 Oct; 14(1):292. PubMed ID: 27737711
[TBL] [Abstract][Full Text] [Related]
27. Clinicopathological features of CpG island methylator phenotype-positive colorectal cancer and its adverse prognosis in relation to KRAS/BRAF mutation.
Lee S; Cho NY; Choi M; Yoo EJ; Kim JH; Kang GH
Pathol Int; 2008 Feb; 58(2):104-13. PubMed ID: 18199160
[TBL] [Abstract][Full Text] [Related]
28. DNA methylation epigenotype and clinical features of NRAS-mutation(+) colorectal cancer.
Takane K; Akagi K; Fukuyo M; Yagi K; Takayama T; Kaneda A
Cancer Med; 2017 May; 6(5):1023-1035. PubMed ID: 28378457
[TBL] [Abstract][Full Text] [Related]
29. Multi gene mutation signatures in colorectal cancer patients: predict for the diagnosis, pathological classification, staging and prognosis.
Zhuang Y; Wang H; Jiang D; Li Y; Feng L; Tian C; Pu M; Wang X; Zhang J; Hu Y; Liu P
BMC Cancer; 2021 Apr; 21(1):380. PubMed ID: 33836681
[TBL] [Abstract][Full Text] [Related]
30. G12V and G12C mutations in the gene KRAS are associated with a poorer prognosis in primary colorectal cancer.
Hayama T; Hashiguchi Y; Okamoto K; Okada Y; Ono K; Shimada R; Ozawa T; Toyoda T; Tsuchiya T; Iinuma H; Nozawa K; Matsuda K
Int J Colorectal Dis; 2019 Aug; 34(8):1491-1496. PubMed ID: 31309326
[TBL] [Abstract][Full Text] [Related]
31. Comprehensive analysis of mutational and clinicopathologic characteristics of poorly differentiated colorectal neuroendocrine carcinomas.
Lee SM; Sung CO
Sci Rep; 2021 Mar; 11(1):6203. PubMed ID: 33737597
[TBL] [Abstract][Full Text] [Related]
32. Perineural invasion is associated with poor prognosis of colorectal cancer: a retrospective cohort study.
Cao Y; Deng S; Yan L; Gu J; Li J; Wu K; Cai K
Int J Colorectal Dis; 2020 Jun; 35(6):1067-1075. PubMed ID: 32179991
[TBL] [Abstract][Full Text] [Related]
33. Mutation Status and Prognostic Value of KRAS and BRAF in Southeast Iranian Colorectal Cancer Patients: First Report from Southeast of Iran.
Yari A; Samoudi A; Afzali A; Karam ZM; Karimaldini NK; Abadi MFS; Ziasistani M; Zangouey MR; Dabiri S
J Gastrointest Cancer; 2021 Jun; 52(2):557-568. PubMed ID: 32495109
[TBL] [Abstract][Full Text] [Related]
34. BRAF-mutated, microsatellite-stable adenocarcinoma of the proximal colon: an aggressive adenocarcinoma with poor survival, mucinous differentiation, and adverse morphologic features.
Pai RK; Jayachandran P; Koong AC; Chang DT; Kwok S; Ma L; Arber DA; Balise RR; Tubbs RR; Shadrach B; Pai RK
Am J Surg Pathol; 2012 May; 36(5):744-52. PubMed ID: 22314188
[TBL] [Abstract][Full Text] [Related]
35. Correlation between mitochondrial TRAP-1 expression and lymph node metastasis in colorectal cancer.
Gao JY; Song BR; Peng JJ; Lu YM
World J Gastroenterol; 2012 Nov; 18(41):5965-71. PubMed ID: 23139614
[TBL] [Abstract][Full Text] [Related]
36. Prognostic relevance of KRAS and BRAF mutations in Japanese patients with colorectal cancer.
Nakanishi R; Harada J; Tuul M; Zhao Y; Ando K; Saeki H; Oki E; Ohga T; Kitao H; Kakeji Y; Maehara Y
Int J Clin Oncol; 2013 Dec; 18(6):1042-8. PubMed ID: 23188063
[TBL] [Abstract][Full Text] [Related]
37. Mutation patterns and prognostic analysis of BRAF/KRAS/PIK3CA in colorectal cancer.
Wang C; Pan D
J Clin Lab Anal; 2022 Jun; 36(6):e24444. PubMed ID: 35435290
[TBL] [Abstract][Full Text] [Related]
38. Correlation between RAS Test Results and Prognosis of Metastatic Colorectal Cancer Patients: a Report from Western Iran.
Payandeh M; Shazad B; Sadeghi M; Shahbazi M
Asian Pac J Cancer Prev; 2016; 17(4):1729-32. PubMed ID: 27221845
[TBL] [Abstract][Full Text] [Related]
39. Prognostic Value of KRAS Gene Mutation on Survival of Patients with Peritoneal Metastases of Colorectal Adenocarcinoma.
Díez-Alonso M; Mendoza-Moreno F; Gómez-Sanz R; Matías-García B; Ovejero-Merino E; Molina R; Soto-Schütte S; San Juan A; Gutierrez-Calvo A
Int J Surg Oncol; 2021; 2021():3946875. PubMed ID: 34557315
[TBL] [Abstract][Full Text] [Related]
40. Thymidine kinase 1 expression in ovarian serous adenocarcinoma is superior to Ki-67: A new prognostic biomarker.
Wang J; Liu Q; Zhou X; He Y; Guo Q; Shi Q; Eriksson S; Zhou J; He E; Skog S
Tumour Biol; 2017 Jun; 39(6):1010428317706479. PubMed ID: 28651488
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
